Abstract Objective To observe changes in the expression of autophagy-related proteins, Beclin-1 and LC3, in the hippocampal tissue of neonatal rats with hypoxic-ischemic brain damage (HIBD) at different time points, and to investigate the effect of rapamycin (Ra) on the expression of the above two proteins. Methods A total of 108 7-dayold Sprague-Dawley rats were randomly divided into sham, HIBD, and Ra groups (n=36 each). The HIBD model was established using the modified Rice method. For sham rats, only the left common carotid artery was separated without ligation or hypoxic treatment. For Ra-treated rats, 0.5 mg/kg Ra was administered by an intraperitoneal injection 1 hour before model establishment. The rats were anesthetized and sacrificed to collect brain tissues at 0, 6, 12, 24, 48, and 72 hours after model establishment. Changes in the expression of Beclin-1 and LC3 proteins in rat hippocampus were examined by Western blot. Results The expression level of Beclin-1 in HIBD rats began to increase at 0 hour, peaked at 24 hours, and then declined thereafter, similar as those of Beclin-1 and LC3-II in Ra-treated rats. The expression level of LC3-II in HIBD rats began to increase at 0 hour, peaked at 12 hours, and then declined thereafter. At all time points, both Beclin-1 and LC3-II expression levels were significantly higher in HIBD and Ra-treated rats than in sham rats (P<0.05); except LC3-II at 12 hours, Beclin-1 and LC3-II expression levels were significantly higher in Ra-treated rats than in HIBD rats (P<0.05). Conclusions Hypoxia-ischemia activates autophagy in rat hippocampal cells, while Ra enhances the expression process of autophagy.
About author:: 10.7499/j.issn.1008-8830.2015.04.022
Cite this article:
LI Rong-Hu,YU Lun,MIAO Po et al. Changes in expression of autophagy-related proteins, Beclin-1 and LC3, and effects of rapamycin on their expression in hypoxic-ischemic hippocampus[J]. CJCP, 2015, 17(4): 400-404.
LI Rong-Hu,YU Lun,MIAO Po et al. Changes in expression of autophagy-related proteins, Beclin-1 and LC3, and effects of rapamycin on their expression in hypoxic-ischemic hippocampus[J]. CJCP, 2015, 17(4): 400-404.
Perlman M, Shah PS. Hypoxic-ischemic encephalopathy: challenges in outcome and prediction[J]. J Pediatr, 2011, 158(2 Suppl): e51-e54.
[4]
Allen KA, Brandon DH. Hypoxic-ischemic encephalopathy: pathophysiology and experimental treatments[J]. Newborn Infant Nurs Rev, 2011, 11(3): 125-133.
[5]
Vannueei RC, Vannucci SJ. Perinatal hypoxic-isehemic brain damage: evolution of an animal model[J]. Dev Neurosci, 2005, 27(2-4): 81-86.
[6]
Deatrick KB, Luke CE, Elfline MA, et al. The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling[J]. J Vasc Surg, 2013, 58(5): 1375-1384.
[7]
Rami A, Langhagen A, SteigerS. Focal cerebral ischemia induces upregulation of Beclin 1 and autophagy-like cell death[J]. Neurobiol Dis, 2008, 29(1): 132-141.
[8]
Kabeya Y, Mizushima N, Yamamoto A, et al. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending On form-II formation[J]. J Cell Sci, 2004, 117(13): 2805-2812.
[9]
Carloni S, Girelli S, Scopa C, et al. Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxiaischemia[ J]. Autophagy, 2010, 6(3): 366-377.
[10]
Ginet V, Puyal J, Clarke PGH, et al. Enhancement of autophagic flux after neonatal cerebral hypoxia-ischemia and its regionspecific relationship to apoptotic mechanisms[J]. Am J Pathol, 2009, 175(5): 1962-1974.
[11]
Jung CH, Ro SH, Cao J, et al. mTOR regulation of autophagy[J]. FEBS Lett, 2010, 584(7): 1287-1295.
Coto-Montes A, Boga JA, Rosales-Corral S, et al. Role of melatonin in the regulation of autophagy and mitophagy: a review[J]. Mol Cell Endocrinol, 2012, 361(1/2): 12-23.
